How does methyldopa compare to angiotensin receptor blockers (ARBs) in managing hypertension, particularly in terms of efficacy, safety and tolerability?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa is less effective than ARBs in controlling hypertension but is safer in pregnancy. Tolerability of methyldopa is lower due to more central nervous system side effects.